IN.PACT 014 Paclitaxel DCB Shows Comparable Effectiveness, No Safety Concerns vs. PTA Below the Knee
The IN.PACT 014 paclitaxel drug-coated balloon (DCB) showed no difference in effectiveness and no safety concerns compared with percutaneous transluminal angioplasty (PTA) in chronic limb ischemia (CLI) patients with chronic total occlusions (CTOs) in the infrapopliteal arteries, according to study results presented Sunday at the TCT Connect virtual conference.